TOP-53: Antineoplastic podophyllotoxin DNA topoisomerase II inhibitor

Drugs of the Future

Volumn 21, Issue 11, 1996, Pages 1136-1139

  Leeson, P A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; PODOPHYLLOTOXIN DERIVATIVE; TOP 53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CELL LINE; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; LEUKEMIA P 388; LUNG CANCER; NONHUMAN; SHORT SURVEY; TUMOR CELL;

EID: 0030468586     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.11.382475     Document Type: Article

References (23)

1. Terada, T., Fujimoto, K., Nomura, M., Yamashita, J., Wierzba, K., Yamazaki, R., Shibata, J., Sugimoto, Y., Yamada, Y. Antitumor agents. 3. Synthesis and biological activity of 4β-alkyl derivatives containing hydroxy, amino, and amido groups of 4′-O-demethyl-4-desoxypodophyllotoxin as antitumor agents. J Med Chem 1993, 36: 1689-99.
2. Terada, T., Fujimoto, K., Nomura, M., Yamashita, J., Takeda, S., Kobunai, T., Yamaguchi, H., Wierzba, K. (Taiho Pharm. Co., Ltd.). 4-Desoxy-4-epipodophyllotoxin deriv. or pharmaceutically aceptable salt thereof. EP 522173, JP 93503298, WO 9212982.
3. Wang, J.C. DNA topoisomerases. Annu Rev Biochem 1985, 54: 665-97.
4. Liu, L. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989, 58: 351-75.
5. D'Arpa, P., Liu, L. Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 1989, 989: 163-77.
6. Watt, P.M., Hickson, I.D. Structure and function of type II DNA topoisomerases. Biochem J 1994, 303: 681-95.
7. Isaacs, R.J., Davies, S.L., Wells, N.J., Harris, A.L. Topoisomerases IIalpha and beta as therapy targets in breast cancer. Anti-Cancer Drugs 1995, 6: 195-211.
8. Merino, A., Madden, K.R., Lane, W.S., Champoux, J.J., Reinberg, D. DNA topoisomerase I is involved in both repression and activation of transcription. Nature 1993, 365: 227-32.
9. Kretzschmar, M., Meisterernst, M., Roeder, R.G. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc Natl Acad Sci USA 1993, 90: 11508-12.
10. Bodley, A., Liu, L. F. Topoisomerases as novel targets for cancer chemotherapy. Biotechnology 1988, 6: 1315-8.
11. Schneider, E., Hsiang, Y.-H., Liu, L.F. DNA topoisomerase as anticancer drug targets. Adv Pharmacol 1990, 21: 149-83.
12. Chen, A.Y., Liu, L.F. DNA topoisomerases: Essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 1994, 34: 191-218.
13. Tewey, K.M., Rowe, T.C., Yang, L., Halligan, B.D., Liu, L.F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984, 226: 466-8.
14. Issel, B.F., Muggia, F.M., Carter, S.K. Etoposide (VP-16) Current Status and New Developments, Academic Press, New York, 1984.
15. Kobunai, T., Yoshida, M., Saito, H., Nomura, N., Takeda, S., Wierzba, K., Terada, T., Yamazaki, R., Yamada, Y., Unemi, N. The investigation of new inhibitors of DNA topoisomerase II. 52nd Annu Meet Jpn Cancer Assoc (Oct 5-7, Sendai) 1993, Abst 2401.
16. Utsugi, T., Kobunai, T., Matsuo, K., Shibata, J., Sugimoto, Y., Wierzba, K., Yamada, Y., Tsuruo, T. Antitumor activity of novel podophyllotoxin derivative TOP-53 [I]. 52nd Annu Meet Jpn Cancer Assoc (Oct 5-7, Sendai) 1993, Abst 2400.
17. Saito, H., Yoshida, M., Nakano, K., Fujioka, A., Kobunai, T., Nomura, N., Takeda, S., Unemi, N. Antitumor activity of novel podophyllotoxin derivative, TOP-53 against various lung cancers. 53rd Annu Meet Jpn Cancer Assoc (Oct 19-21, Nagoya) 1994, Abst 2237.
18. Kobunai, T., Saito, H., Yoshida, M., Toko, T., Takeda, S., Unemi, N. In vitro and in vivo antitumor activity against lung cancer of TOP-53, a novel podophyllotoxin derivative. Proc Amer Assoc Cancer Res 1994, 35: Abst 2154.
19. Kobunai, T., Yoshida, M., Saito, H., Nomura, N., Takeda, S., Unemi, N. The mode of action of novel podophyllotoxin derivative, TOP-53. 53rd Annu Meet Jpn Cancer Assoc (Oct 19-21, Nagoya) 1994, Abst 2236.
20. Kobunai, T., Saito, H., Yoshida, M., Utsugi, T., Yamada, Y. Antitumor activity of TOP-53, a novel podophyllotoxin derivative, against several human lung cancer xenografts. 55th Annu Meet Jpn Cancer Assoc (Oct 10-12, Yokohama) 1996, Abst 2373.
21. Kobunai, T., Saito, H., Yoshida, M., Utsugi, T., Terada, T., Yamada, Y. Antitumor activity of TOP-53, a novel podophyllotoxin derivative. Proc Amer Assoc Cancer Res 1996, 37: Abst 2914.
22. Yoshida, M., Kobunai, T., Utsugi, T., Wierzba, K., Yamada, Y. Relationship between lung distribution of TOP-53 and its interaction with phospholipids. 55th Annu Meet Jpn Cancer Assoc (Oct 10-12, Yokohama) 1996, Abst 2467.
23. Utsugi, T., Shibata, J., Sugimoto, Y., Aoyagi, K., Wierzba, K., Kobunai, T., Terada, T., Oh-hara, T., Tsuruo, T., Yamada, Y. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Cancer Res 1996, 56: 2809-14.